Asensus Surgical Inc (ASXC)

[Domino]

The truth hurts. RASD platforms shouldn’t. People attempting to profit from a RASD that doesn’t benefit the patient are all about making money, either from lack of understanding of greed. Nevertheless, when clinical data shows a platform isn’t viable, proper DD should allow potential investors to know if they are being victims of a pump and dump.

TRXC was exposed for attempting to market 2 non viable platforms only to generate profits for management, not investors nor better patient outcomes.